• Health & Medicine

Viruses may boost immunotherapy success

Viruses may improve the success rate of immunotherapy treatments, according to two new studies. Viruses may improve the success rate of immunotherapy treatments, according to two new studies.

8 September 2017

• Personal Stories

Finding PEACE and remembering my brother Mark – Dave’s story

Dave lost his twin brother to skin cancer at just 28. Here, Dave tells us Mark’s inspiring story through his cancer. Dave lost his twin brother to skin cancer at just 28. Here, Dave tells us Mark’s inspiring story through his cancer.

1 August 2017

• Health & Medicine

Personalised vaccines to treat skin cancer show promise in small studies

Personalised vaccines have been used to successfully treat melanoma (skin cancer) patients in two small studies. Personalised vaccines have been used to successfully treat melanoma (skin cancer) patients in two small studies.

6 July 2017

• Health & Medicine
• Science & Technology

ASCO 2017: 4 ways treatment could change following world’s largest cancer conference

Targeted treatment up front improves survival for advanced prostate cancer, and we predict a change in thinking for precision cancer medicine. Targeted treatment up front improves survival for advanced prostate cancer, and we predict a change in thinking for precision cancer medicine.

19 June 2017

• Health & Medicine

Combined immunotherapy could help control melanoma that has spread to the brain

A combination of two immunotherapy drugs is safe to give to patients with melanoma that has spread to the brain, and could help control the disease. A combination of two immunotherapy drugs is safe to give to patients with melanoma that has spread to the brain, and could help control the disease.

4 June 2017

• Science & Technology

Study suggests why an immunotherapy drug works in some melanoma patients but not in others

Matching tumour size to the body’s immune response could help doctors tailor immunotherapy treatments for melanoma patients whose disease has spread. Matching tumour size to the body’s immune response could help doctors tailor immunotherapy treatments for melanoma patients whose disease has spread.

12 April 2017

• Health & Medicine

Long term benefits of immunotherapy emerging for some patients, though key questions remain

A number of cancer clinical trials involving immunotherapy treatments appear to be showing promise, according to new research. A number of cancer clinical trials involving immunotherapy treatments appear to be showing promise, according to new research.

10 April 2017

• Science & Technology

Watching how ‘young’ cells move gives clues on skin cancer spread

A new early stage study sheds some light on how a molecule helps 'young' skin cells move, which could tell us more about skin cancer. A new early stage study sheds some light on how a molecule helps 'young' skin cells move, which could tell us more about skin cancer.

23 February 2017

• Health & Medicine

Sun exposure at work could lead to one skin cancer death a week

Working in the sun could lead to one death and around five new cases of melanoma skin cancer a week. Working in the sun could lead to one death and around five new cases of melanoma skin cancer a week.

18 January 2017

• Science & Technology

Gene discovery could shed light on how cancer cells spread

UK scientists have revealed a number of genes that could play a role in how cancer cells spread through the body. UK scientists have revealed a number of genes that could play a role in how cancer cells spread through the body.

11 January 2017

• Health & Medicine
• Science & Technology

NCRI Cancer Conference 2016: Day 4 – liver cancer, obesity, immunotherapy poo predictions and more

Read our final roundup from this year's NCRI Cancer Conference, including how bacteria in the gut could help predict if immunotherapy will work. Read our final roundup from this year's NCRI Cancer Conference, including how bacteria in the gut could help predict if immunotherapy will work.

10 November 2016

• Health & Medicine

Gut microbes linked to immunotherapy response in melanoma patients

Patients with malignant melanoma are more likely to respond to immunotherapy treatment if they had greater diversity in their gut bacteria. Patients with malignant melanoma are more likely to respond to immunotherapy treatment if they had greater diversity in their gut bacteria.

7 November 2016